z-logo
open-access-imgOpen Access
High Elmo1 expression aggravates and low Elmo1 expression prevents diabetic nephropathy
Author(s) -
Catherine K. Hathaway,
Albert S. Chang,
Ruriko Grant,
HyungSuk Kim,
Victoria J. Madden,
C. Robert Bagnell,
J. Charles Jennette,
Oliver Smithies,
Masao Kakoki
Publication year - 2016
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.1600511113
Subject(s) - diabetic nephropathy , medicine , nephropathy , endocrinology , diabetes mellitus , kidney disease , chemistry
Significance About one-third of patients with type 1 diabetes mellitus develop nephropathy, which often progresses to end-stage renal diseases. The present study demonstrates that below-normal Elmo1 expression in mice ameliorates the albuminuria and glomerular histological changes resulting from long-standing type 1 diabetes, whereas above-normal Elmo1 expression makes both worse. Increasing Elmo1 expression leads to aggravation of oxidative stress markers and enhances the expression of fibrogenic genes. Suppressing Elmo1 action in human patients could be a promising option for treating/preventing the progressive deterioration of renal function in diabetes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom